ClinicalTrials.govpublic full text
Dose-attenuated IST and Hetrombopag in Elderly (≥65 Years) Patients With Severe Aplastic Anemia
sever aplastic anaemia, elderly (people aged 65 or more), immunosuppressive treatment, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 1008938
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.